Ebitda Zmiana Data
AstraZeneca USD 5.67B 1.29B 2026-03
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 3.51B 734M 2026-06
GRIFOLS EUR 473M 120M 2026-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Qiagen NV USD 148.09M 101.6M 2026-03
UCB EUR 1.6B 570M 2025-12